Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

The impact of duration of antibiotic exposure on bacterial resistance predictions using in vitro dynamic models.

Smirnova MV, Vostrov SN, Strukova EV, Dovzhenko SA, Kobrin MB, Portnoy YA, Zinner SH, Firsov AA.

J Antimicrob Chemother. 2009 Oct;64(4):815-20. doi: 10.1093/jac/dkp287. Epub 2009 Aug 11.

PMID:
19671586
2.

Linezolid pharmacodynamics with Staphylococcus aureus in an in vitro dynamic model.

Strukova EN, Smirnova MV, Vostrov SN, Lubenko IY, Firsov AA, Zinner SH, Portnoy YA.

Int J Antimicrob Agents. 2009 Mar;33(3):251-4. doi: 10.1016/j.ijantimicag.2008.09.006. Epub 2008 Dec 17.

PMID:
19095420
3.

Enrichment of resistant Staphylococcus aureus at ciprofloxacin concentrations simulated within the mutant selection window: bolus versus continuous infusion.

Firsov AA, Smirnova MV, Strukova EN, Vostrov SN, Portnoy YA, Zinner SH.

Int J Antimicrob Agents. 2008 Dec;32(6):488-93. doi: 10.1016/j.ijantimicag.2008.06.031. Epub 2008 Sep 14.

PMID:
18790614
4.

Telavancin and vancomycin pharmacodynamics with Staphylococcus aureus in an in vitro dynamic model.

Lubenko IY, Strukova EV, Smirnova MV, Vostrov SN, Portnoy YA, Zinner SH, Firsov AA.

J Antimicrob Chemother. 2008 Nov;62(5):1065-9. doi: 10.1093/jac/dkn288. Epub 2008 Jul 17.

PMID:
18635520
5.

Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model.

Firsov AA, Smirnova MV, Lubenko IY, Vostrov SN, Portnoy YA, Zinner SH.

J Antimicrob Chemother. 2006 Dec;58(6):1185-92. Epub 2006 Oct 5.

PMID:
17028094
6.
7.
8.

Comparative pharmacodynamics of the new fluoroquinolone ABT492 and ciprofloxacin with Escherichia coli and Pseudomonas aeruginosa in an in vitro dynamic model.

Zinner SH, Vostrov SN, Alferova IV, Lubenko IY, Portnoy YA, Firsov AA.

Int J Antimicrob Agents. 2004 Aug;24(2):173-7.

PMID:
15288317
9.

ABT492 and levofloxacin: comparison of their pharmacodynamics and their abilities to prevent the selection of resistant Staphylococcus aureus in an in vitro dynamic model.

Firsov AA, Vostrov SN, Lubenko IY, Arzamastsev AP, Portnoy YA, Zinner SH.

J Antimicrob Chemother. 2004 Jul;54(1):178-86. Epub 2004 Jun 9.

PMID:
15190041
10.
11.
12.

In vitro pharmacodynamic evaluation of the mutant selection window hypothesis using four fluoroquinolones against Staphylococcus aureus.

Firsov AA, Vostrov SN, Lubenko IY, Drlica K, Portnoy YA, Zinner SH.

Antimicrob Agents Chemother. 2003 May;47(5):1604-13.

13.

Simulated in vitro quinolone pharmacodynamics at clinically achievable AUC/MIC ratios: advantage of I E over other integral parameters.

Firsov AA, Zinner SH, Lubenko IY, Portnoy YA, Vostrov SN.

Chemotherapy. 2002;48(6):275-9.

PMID:
12673102
14.

Species-independent pharmacodynamics of gemifloxacin and ciprofloxacin with Haemophilus influenzae and Moraxella catarrhalis in an in vitro dynamic model.

Portnoy YA, Vostrov SN, Lubenko IY, Zinner SH, Firsov AA.

Int J Antimicrob Agents. 2002 Sep;20(3):201-5.

PMID:
12385699
15.

AUC/MIC relationships to different endpoints of the antimicrobial effect: multiple-dose in vitro simulations with moxifloxacin and levofloxacin.

Firsov AA, Zinner SH, Vostrov SN, Portnoy YA, Lubenko IY.

J Antimicrob Chemother. 2002 Oct;50(4):533-9.

PMID:
12356798
16.
17.

Comparative pharmacodynamics of azithromycin and roxithromycin with S. pyogenes and S. pneumoniae in a model that simulates in vitro pharmacokinetics in human tonsils.

Firsov AA, Zinner SH, Vostrov SN, Kononenko OV, Portnoy YA, Shustova LV, Kadenatsi IB.

J Antimicrob Chemother. 2002 Jan;49(1):113-9.

PMID:
11751774
18.

Comparative anti-staphylococcal effects of gemifloxacin and trovafloxacin in an in vitro dynamic model in terms of AUC/MIC and dose relationships.

Zinner SH, Vostrov SN, Lubenko IY, Portnoy YA, Cornaglia G, Firsov AA.

Diagn Microbiol Infect Dis. 2001 Aug;40(4):167-71.

PMID:
11576789
19.
20.

Gemifloxacin and ciprofloxacin pharmacodynamics in an in-vitro dynamic model: prediction of the equivalent AUC/MIC breakpoints and doses.

Firsov AA, Zinner SH, Lubenko IYu, Vostrov SN.

Int J Antimicrob Agents. 2000 Dec;16(4):407-14.

PMID:
11118849
21.

Comparative pharmacodynamics of moxifloxacin and levofloxacin in an in vitro dynamic model: prediction of the equivalent AUC/MIC breakpoints and equiefficient doses.

Firsov AA, Lubenko IY, Vostrov SN, Kononenko OV, Zinner SH, Portnoy YA.

J Antimicrob Chemother. 2000 Nov;46(5):725-32.

PMID:
11062191
22.
23.

Prediction of the antimicrobial effects of trovafloxacin and ciprofloxacin on staphylococci using an in-vitro dynamic model.

Firsov AA, Vasilov RG, Vostrov SN, Kononenko OV, Lubenko IY, Zinner SH.

J Antimicrob Chemother. 1999 Apr;43(4):483-90.

PMID:
10350376
24.
25.

MIC-based interspecies prediction of the antimicrobial effects of ciprofloxacin on bacteria of different susceptibilities in an in vitro dynamic model.

Firsov AA, Vostrov SN, Shevchenko AA, Zinner SH, Cornaglia G, Portnoy YA.

Antimicrob Agents Chemother. 1998 Nov;42(11):2848-52.

27.

Inter- and intraquinolone predictors of antimicrobial effect in an in vitro dynamic model: new insight into a widely used concept.

Firsov AA, Shevchenko AA, Vostrov SN, Zinner SH.

Antimicrob Agents Chemother. 1998 Mar;42(3):659-65.

29.

[A system for screening natural immunosuppressors].

Bibikova MV, Rybakova AM, Vostrov SN, Spiridonova IA, Ivanitskaia LP.

Antibiot Khimioter. 1991 Mar;36(3):17-20. Russian.

PMID:
1877869
30.

[Grouping of Micromonospora based on their cultural-morphologic features, antibiotic-sensitivity and formation of antibiotics].

Bibikova MV, Ivanitskaia LP, Singal EM, Vostrov SN.

Mikrobiologiia. 1989 Jul-Aug;58(4):635-41. Russian.

PMID:
2622409
31.

[Direct screening for producers of antibiotics among the Micromonospora].

Bibikova MV, Ivanitskaia LP, Singan EM, Vostrov SN.

Antibiot Khimioter. 1989 Apr;34(4):248-51. Russian.

PMID:
2751380
32.

[Formation of antibiotic JI-20B by a culture of Streptomyces flavovirens].

Ivanitskaia LP, Singal EM, Tań≠g MM, Zhdanovich IuV, Vostrov SN.

Antibiotiki. 1982 Oct;27(10):724-7. Russian.

PMID:
6985565
33.

[Optimization of the makeup of the fermentation nutrient medium for detecting antibiotic producers among Micromonospora].

Bibikov MV, Selekhova GN, Vostrov SN, Ivanitskaia LP, Fishman VM.

Antibiotiki. 1980 Dec;25(12):899-904. Russian.

PMID:
7469394
34.

[Methodological procedures for detecting antibiotic producers among cultures of the family Micromonosporaceae].

Bibikova MV, Ivanitskaia LP, Singal EM, Vostrov SN.

Antibiotiki. 1979 Dec;24(12):903-6. Russian.

PMID:
391144
35.

[Formation of broad-spectrum antibiotics by cultures of the genus Micromonospora].

Vostrov SN, Bibikova MV, Ivanitskaia LP.

Antibiotiki. 1979 Apr;24(4):243-6. Russian.

PMID:
443785
36.

[Directed isolation of Micromonospora generic cultures on a selective medium with gentamycin].

Ivanitskaia LP, Singal EM, Bibikova MV, Vostrov SN.

Antibiotiki. 1978 Aug;23(8):690-2. Russian.

PMID:
686691

Supplemental Content

Loading ...
Support Center